title: Response to letter to the editor by Wei et al.
authors: Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; Knowledge and Evaluation Research Unit, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
authors: Tarig
authors: T
authors: Elraiyah
authors: Knowledge and Evaluation Research Unit, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; Mayo Graduate School, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
authors: Michael R
authors: MR
authors: Gionfriddo
authors: Knowledge and Evaluation Research Unit, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; Division of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Electronic address: Murad.mohammad@mayo.edu.
authors: Mohammad Hassan
authors: MH
authors: Murad
mesh_terms: D000818:Animals; D004348:Drug Labeling; D006801:Humans; D012516:Osteosarcoma / Q000139:chemically induced* / Q000517:prevention & control*; D019379:Teriparatide / Q000009:adverse effects*
chemical_list: D019379:Teriparatide